A 0 1 0 1 O
negative 2 10 2 10 B-pregnancy
serum 11 16 11 16 I-pregnancy
β 17 18 17 18 I-pregnancy
- 18 19 18 19 I-pregnancy
human 19 24 19 24 I-pregnancy
chorionic 25 34 25 34 I-pregnancy
gonadotropin 35 47 35 47 I-pregnancy
( 48 49 48 49 I-pregnancy
HCG 49 52 49 52 I-pregnancy
) 52 53 52 53 I-pregnancy
pregnancy 54 63 54 63 I-pregnancy
test 64 68 64 68 O
is 69 71 69 71 O
required 72 80 72 80 O
for 81 84 81 84 O
females 85 92 85 92 B-gender
of 93 95 93 95 O
childbearing 96 108 96 108 O
potential 109 118 109 118 O
only 119 123 119 123 O

Active 0 6 124 130 O
hepatitis 7 16 131 140 B-chronic_disease
C 17 18 141 142 I-chronic_disease
virus 19 24 143 148 O
( 25 26 149 150 O
HCV 26 29 150 153 B-chronic_disease
) 29 30 153 154 O
infection 31 40 155 164 O
defined 41 48 165 172 O
as 49 51 173 175 O
positive 52 60 176 184 O
for 61 64 185 188 O
HCV 65 68 189 192 O
antibody 69 77 193 201 O
and 78 81 202 205 O
having 82 88 206 212 O
detectable 89 99 213 223 O
HCV 100 103 224 227 O
RNA 104 107 228 231 O

Active 0 6 232 238 B-chronic_disease
, 6 7 238 239 I-chronic_disease
serious 8 15 240 247 I-chronic_disease
infections 16 26 248 258 I-chronic_disease
( 27 28 259 260 O
other 28 33 260 265 O
than 34 38 266 270 O
HIV-1 39 44 271 276 B-chronic_disease
infection 45 54 277 286 I-chronic_disease
) 54 55 286 287 O
requiring 56 65 288 297 O
parenteral 66 76 298 308 B-treatment
antibiotic 77 87 309 319 I-treatment
or 88 90 320 322 O
antifungal 91 101 323 333 B-treatment
therapy 102 109 334 341 I-treatment
within 110 116 342 348 O
30 117 119 349 351 B-upper_bound
days 120 124 352 356 I-upper_bound
prior 125 130 357 362 I-upper_bound
to 131 133 363 365 O
baseline 134 142 366 374 O
/ 142 143 374 375 O
Day 143 146 375 378 O
1 147 148 379 380 O

An 0 2 381 383 O
acquired 3 11 384 392 B-chronic_disease
immunodeficiency 12 28 393 409 I-chronic_disease
syndrome 29 37 410 418 I-chronic_disease
( 38 39 419 420 I-chronic_disease
AIDS 39 43 420 424 I-chronic_disease
) 43 44 424 425 I-chronic_disease
- 45 46 426 427 O
indicator 47 56 428 437 O
condition 57 66 438 447 O
with 67 71 448 452 O
onset 72 77 453 458 O
within 78 84 459 465 O
30 85 87 466 468 B-upper_bound
days 88 92 469 473 I-upper_bound
prior 93 98 474 479 I-upper_bound
to 99 101 480 482 O
screening 102 111 483 492 O

Currently 0 9 493 502 O
on 10 12 503 505 O
a 13 14 506 507 O
stable 15 21 508 514 O
2 22 23 515 516 B-treatment
- 23 24 516 517 I-treatment
NRTI 24 28 517 521 I-treatment
containing 29 39 522 532 I-treatment
regimen 40 47 533 540 I-treatment
that 48 52 541 545 O
includes 53 61 546 554 O
a 62 63 555 556 O
3rd 64 67 557 560 O
ARV 68 71 561 564 B-treatment
agent 72 77 565 570 I-treatment
for 78 81 571 574 O
≥ 82 83 575 576 O
6 84 85 577 578 B-lower_bound
consecutive 86 97 579 590 I-lower_bound
months 98 104 591 597 I-lower_bound
prior 105 110 598 603 I-lower_bound
to 111 113 604 606 O
screening 114 123 607 616 O

Evidence 0 8 617 625 O
of 9 11 626 628 O
active 12 18 629 635 B-chronic_disease
pulmonary 19 28 636 645 I-chronic_disease
or 29 31 646 648 O
extra 32 37 649 654 B-chronic_disease
- 37 38 654 655 I-chronic_disease
pulmonary 38 47 655 664 I-chronic_disease
tuberculosis 48 60 665 677 I-chronic_disease
disease 61 68 678 685 O
within 69 75 686 692 O
3 76 77 693 694 B-upper_bound
months 78 84 695 701 I-upper_bound
of 85 87 702 704 O
the 88 91 705 708 O
screening 92 101 709 718 O
visit 102 107 719 724 O

HIV-1 0 5 725 730 B-chronic_disease
infected 6 14 731 739 O

Have 0 4 740 744 O
any 5 8 745 748 O
serious 9 16 749 756 O
or 17 19 757 759 O
active 20 26 760 766 O
medical 27 34 767 774 O
or 35 37 775 777 O
psychiatric 38 49 778 789 B-chronic_disease
illness 50 57 790 797 I-chronic_disease
which 58 63 798 803 O
, 63 64 803 804 O
in 65 67 805 807 O
the 68 71 808 811 O
opinion 72 79 812 819 O
of 80 82 820 822 O
the 83 86 823 826 O
Investigator 87 99 827 839 O
, 99 100 839 840 O
would 101 106 841 846 O
interfere 107 116 847 856 O
with 117 121 857 861 O
treatment 122 131 862 871 B-treatment
, 131 132 871 872 O
assessment 133 143 873 883 O
, 143 144 883 884 O
or 145 147 885 887 O
compliance 148 158 888 898 O
with 159 163 899 903 O
the 164 167 904 907 O
protocol 168 176 908 916 O

Have 0 4 917 921 O
history 5 12 922 929 O
of 13 15 930 932 O
significant 16 27 933 944 O
drug 28 32 945 949 B-allergy_name
sensitivity 33 44 950 961 O
or 45 47 962 964 O
drug 48 52 965 969 O
allergy 53 60 970 977 O

Have 0 4 978 982 O
previously 5 15 983 993 O
participated 16 28 994 1006 O
in 29 31 1007 1009 O
an 32 34 1010 1012 O
investigational 35 50 1013 1028 O
trial 51 56 1029 1034 O
involving 57 66 1035 1044 O
administration 67 81 1045 1059 O
of 82 84 1060 1062 O
any 85 88 1063 1066 O
investigational 89 104 1067 1082 B-treatment
agent 105 110 1083 1088 I-treatment
, 110 111 1088 1089 O
other 112 117 1090 1095 O
than 118 122 1096 1100 O
tenofovir 123 132 1101 1110 B-treatment
, 132 133 1110 1111 O
within 134 140 1112 1118 O
30 141 143 1119 1121 B-upper_bound
days 144 148 1122 1126 I-upper_bound
prior 149 154 1127 1132 I-upper_bound
to 155 157 1133 1135 O
the 158 161 1136 1139 O
study 162 167 1140 1145 O
dosing 168 174 1146 1152 O

Life 0 4 1153 1157 B-clinical_variable
expectancy 5 15 1158 1168 I-clinical_variable
of 16 18 1169 1171 O
< 19 20 1172 1173 O
2 21 22 1174 1175 B-upper_bound
years 23 28 1176 1181 I-upper_bound

No 0 2 1182 1184 O
opportunistic 3 16 1185 1198 B-chronic_disease
infection 17 26 1199 1208 I-chronic_disease
within 27 33 1209 1215 O
30 34 36 1216 1218 B-upper_bound
days 37 41 1219 1223 I-upper_bound
of 42 44 1224 1226 O
study 45 50 1227 1232 O
entry 51 56 1233 1238 O
( 57 58 1239 1240 O
at 58 60 1240 1242 O
baseline 61 69 1243 1251 O
/ 69 70 1251 1252 O
Day 70 73 1252 1255 O
1 74 75 1256 1257 O
) 75 76 1257 1258 O

Plasma 0 6 1259 1265 B-clinical_variable
HIV-1 7 12 1266 1271 I-clinical_variable
RNA 13 16 1272 1275 I-clinical_variable
levels 17 23 1276 1282 I-clinical_variable
< 24 25 1283 1284 O
50 26 28 1285 1287 B-upper_bound
copies 29 35 1288 1294 I-upper_bound
/ 35 36 1294 1295 I-upper_bound
mL 36 38 1295 1297 I-upper_bound
for 39 42 1298 1301 O
≥ 43 44 1302 1303 O
6 45 46 1304 1305 B-lower_bound
consecutive 47 58 1306 1317 I-lower_bound
months 59 65 1318 1324 I-lower_bound
preceding 66 75 1325 1334 O
the 76 79 1335 1338 O
screening 80 89 1339 1348 O
visit 90 95 1349 1354 O

Positive 0 8 1355 1363 O
hepatitis 9 18 1364 1373 B-clinical_variable
B 19 20 1374 1375 I-clinical_variable
surface 21 28 1376 1383 I-clinical_variable
antigen 29 36 1384 1391 I-clinical_variable
or 37 39 1392 1394 O
other 40 45 1395 1400 O
evidence 46 54 1401 1409 O
of 55 57 1410 1412 O
active 58 64 1413 1419 O
hepatitis 65 74 1420 1429 B-chronic_disease
B 75 76 1430 1431 I-chronic_disease
virus 77 82 1432 1437 I-chronic_disease
( 83 84 1438 1439 I-chronic_disease
HBV 84 87 1439 1442 I-chronic_disease
) 87 88 1442 1443 I-chronic_disease
infection 89 98 1444 1453 I-chronic_disease

Pregnant 0 8 1454 1462 B-pregnancy

aged 0 4 1463 1467 B-age
1 5 6 1468 1469 B-lower_bound
month 7 12 1470 1475 I-lower_bound
to 13 15 1476 1478 O
< 16 17 1479 1480 O
18 18 20 1481 1483 B-upper_bound
years 21 26 1484 1489 I-upper_bound
at 27 29 1490 1492 O
baseline 30 38 1493 1501 O
/ 38 39 1501 1502 O
Day 39 42 1502 1505 O
1 43 44 1506 1507 O
( 45 46 1508 1509 O
according 46 55 1509 1518 O
to 56 58 1519 1521 O
requirements 59 71 1522 1534 O
of 72 74 1535 1537 O
the 75 78 1538 1541 O
enrolling 79 88 1542 1551 O
cohort 89 95 1552 1558 O
) 95 96 1558 1559 O

female 0 6 1560 1566 B-gender
adolescents 7 18 1567 1578 O

lactating 0 9 1579 1588 O
females 10 17 1589 1596 B-gender

male 0 4 1597 1601 B-gender

